. "Anagestone acetate"@en . . . . . . . "Anatropin, Neo-Novum"@en . . . . . . . . "24"^^ . . "C[C@H]1C[C@@H]2[C@H][C@@]4C"@en . . . . . . . . . . . . . . . . . . . . . . . . . "Anagestone acetate, sold under the brand names Anatropin and Neo-Novum, is a progestin medication which was withdrawn from medical use due to carcinogenicity observed in animal studies."@en . . "221058"^^ . . . . . . "252301" . "3"^^ . . "225"^^ . . . . . . . . . . . . . . "ORF-1658; Anapregnone acetate; 3-Deketo-6\u03B1-methyl-17\u03B1-acetoxyprogesterone; 6\u03B1-Methyl-17\u03B1-hydroxypregn-4-en-20-one acetate"@en . . . "GNT396G9QT" . . "Anatropin, Neo-Novum"@en . . . . . . "GNT396G9QT"@en . . . . . . . "36"^^ . . . "252301"^^ . . . . . . "1110882179"^^ . . . . "KDLNOQQQEBKBQM-DICPTYMLSA-N"@en . . . . . "Anagestone acetate, sold under the brand names Anatropin and Neo-Novum, is a progestin medication which was withdrawn from medical use due to carcinogenicity observed in animal studies."@en . . "10421"^^ . . . . . "1"^^ . . . . . "49039968"^^ . . . . "3137-73-3" . . . . . . . . . . "[-17-acetyl-6,10,13-trimethyl-1,2,3,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate"@en . . . . . . . . . . . . "3137"^^ . . . . . . . . .